EUCTR2011-000903-41-DE进行中（未招募）不适用
AN OBSERVATIONAL STUDY TO COLLECT FOLLOW-UP CLINICAL DATAFROM KIDNEY TRANSPLANT RECIPIENTS WHO RECEIVED TOFACITINIB(CP-690,550) IN COMPLETED PHASE 2 STUDIES
Pfizer Inc.235 East 42nd Street, New York, NY 10017, USA0 个研究点目标入组 110 人开始时间: 2011年9月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects must meet all of the following criteria to be eligible for enrollment into the trial:
- •1. Subject must meet at least 1 of the following 2 criteria:
- •a. Subjects have discontinued tofacitinib prior to the planned treatment duration of study A3921009 (6 months posttransplant) or study A3921030 (12 months posttransplant); or
- •b. Subjects have not enrolled in the extension studies A3921021 or A3921050.
- •2. Subjects must be willing and able to provide written informed consent with evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all the pertinent
- •aspects of the study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 94
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 16
排除标准
- •Not applicable
研究者
相似试验
进行中（未招募）
不适用
A study to collect follow up clinical data in kidney transplant subjects from two completed studies.EUCTR2011-000903-41-ESPfizer, S.L.U.110
进行中（未招募）
不适用
A study to collect follow up clinical data in kidney transplant subjects from two completed studies.EUCTR2011-000903-41-CZPfizer Inc.110
进行中（未招募）
1 期
A study to collect follow up clinical data in kidney transplant subjects from two completed studies.EUCTR2011-000903-41-BEPfizer Inc.235 East 42nd Street, New York, NY 10017110
进行中（未招募）
不适用
A study to collect follow up clinical data in kidney transplant subjects from two completed studies.KIDNEY TRANSPLANTMedDRA version: 14.1Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-000903-41-ITPFIZER INC.110
进行中（未招募）
不适用
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis - RESTORE™ SIntravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)MedDRA version: 9.0Level: LLTClassification code 10045365EUCTR2005-004105-28-GRPDL BioPharma, Inc.300